339 related articles for article (PubMed ID: 28608122)
1. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
Minig L; Heitz F; Cibula D; Bakkum-Gamez JN; Germanova A; Dowdy SC; Kalogera E; Zapardiel I; Lindemann K; Harter P; Scambia G; Petrillo M; Zorrero C; Zanagnolo V; Rebollo JMC; du Bois A; Fotopoulou C
Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.
Lago V; Minig L; Fotopoulou C
Int J Gynecol Cancer; 2016 Oct; 26(8):1407-14. PubMed ID: 27465900
[TBL] [Abstract][Full Text] [Related]
4. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
Nomura H; Tsuda H; Susumu N; Fujii T; Banno K; Kataoka F; Tominaga E; Suzuki A; Chiyoda T; Aoki D
Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
7. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
9. Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?
Nasioudis D; Mastroyannis SA; Ko EM; Latif NA
Arch Gynecol Obstet; 2018 Jul; 298(1):179-182. PubMed ID: 29785550
[TBL] [Abstract][Full Text] [Related]
10. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
[TBL] [Abstract][Full Text] [Related]
12. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
13. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
Wafa M; Braicu EI; Muallem MZ; Richter R; Taube E; Sehouli J; Grabowski JP
Anticancer Res; 2019 Oct; 39(10):5617-5621. PubMed ID: 31570458
[TBL] [Abstract][Full Text] [Related]
15. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
16. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
[TBL] [Abstract][Full Text] [Related]
17. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
[TBL] [Abstract][Full Text] [Related]
18. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
[TBL] [Abstract][Full Text] [Related]
19. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
20. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
